CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 41 of 48

Rheumatology (Oxford)

Briefs 1,601–1,640 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration

    Cohort studySystemic sclerosis

  2. Rheumatology (Oxford)

    Characteristics of patients initiating treatment with baricitinib and outcomes at follow-up: analysis of BSRBR-RA Registry data

    Cohort studyRA

  3. Rheumatology (Oxford)

    The impact of health literacy: associations with disease activity and medication prescription in patients with rheumatoid arthritis

    Cohort studyRA

  4. Rheumatology (Oxford)

    Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application

    Cohort studyRA

  5. Rheumatology (Oxford)

    Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data

    Secondary analysisSpondyloarthritis & PsA

  6. Rheumatology (Oxford)

    Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis

    Meta-analysisRA

  7. Rheumatology (Oxford)

    Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus

    Mechanistic studyLupus & APS

  8. Rheumatology (Oxford)

    Clinical characteristics of early-onset paediatric systemic lupus erythematosus in a single centre in China

    Cohort studyPediatric

  9. Rheumatology (Oxford)

    CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

    Guideline or statementVasculitis & PMR

  10. Rheumatology (Oxford)

    Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

    Mechanistic studyVasculitis & PMR

  11. Rheumatology (Oxford)

    Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT

    Randomized controlled trialRA

  12. Rheumatology (Oxford)

    Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study

    Cohort studyRA

  13. Rheumatology (Oxford)

    Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis

    Cohort studyVasculitis & PMR

  14. Rheumatology (Oxford)

    Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug

    Cohort studyRA

  15. Rheumatology (Oxford)

    Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide setting

    Cohort studyAcross diseases

  16. Rheumatology (Oxford)

    FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren’s syndrome

    Diagnostic or prognostic studySjögren's & overlap

  17. Rheumatology (Oxford)

    Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study

    Cohort studySpondyloarthritis & PsA

  18. Rheumatology (Oxford)

    A novel TNFRSF1A mutation associated with TNF-receptor-associated periodic syndrome and its metabolic signature

    Cohort studyAutoinflammatory & rare

  19. Rheumatology (Oxford)

    Is Satoyoshi syndrome an autoimmune disease? A systematic review

    Meta-analysisAutoinflammatory & rare

  20. Rheumatology (Oxford)

    PET vascular activity score for predicting new angiographic lesions in patients with Takayasu arteritis: a Chinese cohort study

    Cohort studyVasculitis & PMR

  21. Rheumatology (Oxford)

    Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

    Cross-sectional studyMyositis

  22. Rheumatology (Oxford)

    Using human genetics to understand the epidemiological association between obesity, serum urate, and gout

    Research articleGout & crystals

  23. Rheumatology (Oxford)

    Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis

    Case-control studySpondyloarthritis & PsA

  24. Rheumatology (Oxford)

    The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis

    Mechanistic studySystemic sclerosis

  25. Rheumatology (Oxford)

    High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis

    Cohort studyMyositis

  26. Rheumatology (Oxford)

    Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis

    Meta-analysisRA

  27. Rheumatology (Oxford)

    In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study

    Cohort studySjögren's & overlap

  28. Rheumatology (Oxford)

    The incidence of Kawasaki disease using hospital admissions data for England 2006–2021

    Cohort studyPediatric

  29. Rheumatology (Oxford)

    Dose–response relationships of tea and coffee consumption with gout: a prospective cohort study in the UK Biobank

    Cohort studyGout & crystals

  30. Rheumatology (Oxford)

    Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis

    Cohort studySystemic sclerosis

  31. Rheumatology (Oxford)

    Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study

    Case-control studyRA

  32. Rheumatology (Oxford)

    Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant

    Mechanistic studySystemic sclerosis

  33. Rheumatology (Oxford)

    The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders

    Cross-sectional studyMyositis

  34. Rheumatology (Oxford)

    Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile-onset systemic lupus erythematosus: tolerability and impact on disease activity

    Cohort studyPediatric

  35. Rheumatology (Oxford)

    Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5

    Cohort studyMyositis

  36. Rheumatology (Oxford)

    Lung function trajectory of rheumatoid arthritis–associated interstitial lung disease

    Cohort studyRA

  37. Rheumatology (Oxford)

    Predictors of long-term functional outcomes of juvenile idiopathic arthritis–enthesitis-related arthritis: a single centre experience

    Cross-sectional studyPediatric

  38. Rheumatology (Oxford)

    Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study

    Cohort studyRA

  39. Rheumatology (Oxford)

    Quality standards for the care of people with giant cell arteritis in secondary care

    Guideline or statementVasculitis & PMR

  40. Rheumatology (Oxford)

    Dysbiosis of gut microbiota, a potential mediator of bile acid compositions, and prevalence of hand synovitis: a community-based study

    Cross-sectional studyOsteoarthritis

All 1,905 Briefs in ExploreShowing Briefs 1,601–1,640 of 1,905, newest first